CICP13

Across TCGA pan-cancer cohorts, CICP13 RNA differs between tumor and matched normal tissue in 2 of 18 cancer types tested, making tumor–normal expression one of CICP13’s most consistent transcriptional readouts.

The strongest signal is observed in liver hepatocellular carcinoma (LIHC), where CICP13 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types CICP13 is over-expressed in tumor.

LIHC and KIRP are the cancer types where CICP13 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in CICP13 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
LIHC	All	All	+0.013	.019	2	view →
KIRP	Male	III,IV	+0.012	.043	2	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 2 strongest of 2 lineages.

CICP13–LIHC

Open the LIHC breakdown →